FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
A guide to understanding, implementing, and benefiting from digital pathology and artificial intelligence in the clinical lab
A few months on from the historic CrowdStrike outage, what lessons can clinical labs take away from the incident?
How clinical laboratories and pathology groups can ensure that their digital pathology and AI workflows are HIPAA-compliant
What labs need to know about keeping patients’ data safe when using digital pathology and artificial intelligence-based solutions
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
The company is hiring at least 100 sales representatives this year to spread awareness and uptake of its recently FDA-approved Shield test
Direct-to-consumer (DTC) genetic testing has risen in popularity in recent years—but is it all it’s cracked up to be?
As the field of genetic testing grows, genetic counselors can help labs meet patients’ needs and keep up with new developments